Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

  title={Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.},
  author={Mauro Gacci and Ian Eardley and François A Giuliano and Dimitris Hatzichristou and Steven A. Kaplan and Mario Maggi and Kevin T McVary and Vincenzo G Mirone and Hartmut Porst and Claus G. Roehrborn},
  journal={European urology},
  volume={60 4},

Figures and Tables from this paper

Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors

A critical review of the current literature data about sexual dysfunction as a potential side effect related to drugs commonly used for the treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms finds that silodosin appears to have the highest incidence of ejaculatory disorders.

Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review

EjD concerns almost half of the patients presenting BPH-related LUTS and initial evaluation of EjD impairment is primordial before medical or surgical therapy, regardless of the surgical option.

Sexual Dysfunction Related to Drugs : A Critical

A critical review of the current literature on sexual dysfunction caused by α-blocker and 5-ARI drugs and the use of phosphodiesterase type 5 (PDE5) inhibitors in combination with these drugs to identify possible intervention strategies for sexual dysfunction related to these drugs.

Lower Urinary Tract Symptoms (LUTS) and Sexual Function and Dysfunction

In this chapter, it was attempted to evaluate the impact on patient’s quality of life (QoL), common pathophysiological pathways and therapy aspects of this condition.

Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.

A systematic review and meta-analysis of the available randomized clinical trials reporting the impact of medical treatments for LUTS due to BPH on ejaculatory function found that more the AB is effective over time, greater is the incidence of EjD.

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

The link between lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and sexual dysfunction is well established and many of the medical treatments and almost all surgical treatment impact the ejaculatory function of the patient.

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil

Asian men with LUTS/BPH have similar incidence rates, co-existing ED, comorbid diseases, and risks as non-Asian men and tadalafil is the only therapy recommended for treatment of co- existing BPH and ED, while other therapies have unwanted ED side effects.

The Complex Relationship Between Lower Urinary Tract Symptoms and Sexual Health

Although the authors are beginning to acknowledge the link between LUTS and sexual health, a better understanding of the underlying biochemistry is needed and only then can more effective therapies be developed.

A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction

Tadalafil is today a new treatment alternative to other established drugs for LUTS such as the α-adrenergic antagonists or 5α-reductase inhibitors, however, it is not just an alternative, since sexual adverse events associated with these drugs are avoided and tadalafils is the only drug that can treat both ED and LUTs at the same time.



Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia

  • R. Rosen
  • Medicine
    Current opinion in urology
  • 2006
Owing to the link between LUTS/BPH and male sexual dysfunction, patients presenting with one of these conditions should be routinely screened for the other condition, and patients with LUTs/B PH should be monitored for treatment-related sexual outcomes.

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function

  • F. Lowe
  • Psychology, Medicine
    BJU international
  • 2005
It can be concluded that α1‐AR antagonists constitute a first‐line therapy for LUTS/BPH because they combine good treatment efficacy with very few adverse effects on sexual function.

Impact of medical treatments for benign prostatic hyperplasia on sexual function

Because treatment options for managing BPH have different effects on sexuality, the sexual dimension should be considered when assessing patients’ expectations and the choice of treatment.

Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening

The findings in a prostate cancer screening population confirm that LUTS is an age-independent predictor of ED and demonstrate that not only the presence of LUTs increases the likelihood of developing ED, but the severity of L UTS is associated with the intensity of ED.

Sexual dysfunction in men with lower urinary tract symptoms.

Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life

Optimal treatment for men with BPH requires the use of agents that demonstrate efficacy and safety with fewer sexual side effects, with a focus on the effects of different pharmacological agents on sexual function.